PATIENT INFORMATION SHEET.

The article offers information about the risperidone, its use, and risk and effects associated with it. It mentions that risperidone is in a class of medications that call atypical antipsychotics, and states that it is approved by the U.S. Food and Drug Administration (FDA)approved indications for the treatment of schizophrenia in adults and in adolescents. It also mentions several potential risks and side effects of risperidone therapy such as it increase mortality in elderly patients.